Ixazomib/Enleri medical insurance price analysis: latest price and reimbursement policy in 2025

Ixazomib is an oral proteasome inhibitor mainly used to treat multiple myeloma (MM). This is a cancer that affects the bone marrow, causing the proliferation of abnormal plasma cells, which in turn affects the production of normal blood cells. Ixazomib is often used in combination with other drugs and is indicated for adults who have received at least one prior therapy, making it important in the treatment of multiple myeloma.

In China, the original drug of ixazomib has been launched and has been included in Class B medical insurance. This policy reduces the financial burden on patients. Common capsule preparations come in multiple specifications, including4mg, 3mg and 2.5mg. Each box usually contains 3 plates, each with 1 capsule. According to market conditions, the price of these specifications is approximately more than 10,000 yuan. Although the price is higher than some other drugs, many people still choose to use it compared to its therapeutic effect and improvement in patients' quality of life.

It is worth noting that for those patients who are not eligible for medical insurance, they can only pay for ixazomib out of pocket, which may cause certain pressure on patients with limited financial conditions. Therefore, patients should fully communicate with their doctors before receiving treatment to understand the therapy and related costs.

The price of the original ixazomib drug in overseas markets is relatively high, and the price per box may usually reach more than 10,000 US dollars. This price has forced many patients to consider other avenues when looking for a financial solution. In addition, there are also some generic drugs of ixazomib in overseas markets. For example, a 4mg product produced by a pharmaceutical factory in Laos may cost less than 1,000 yuan per box. These generic drugs provide a more economical option, but patients need to ensure the source and quality of the drug when choosing to ensure its safety and effectiveness.

Reference materials:https://www.ninlaro.com/